GSE125403 7 V 0 VENETOCLAX HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE125403 7 V 0 VENETOCLAX HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE125403 7 V 0 VENETOCLAX HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE125403 7 V 0 VENETOCLAX HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE125403 7 V 0 VENETOCLAX HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

interleukin 3 receptor subunit alpha

Gene

Rho GTPase activating protein 11B

Gene

speedy/RINGO cell cycle regulator family member E12

Gene

DIRAS family GTPase 1

Gene

myosin XVB

Gene

gamma-glutamyltransferase 5

Gene

coiled-coil domain containing 144A

Gene

peroxisomal biogenesis factor 13

Gene

ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase

Gene

chloride voltage-gated channel Ka

  • Gene

    interleukin 3 receptor subunit alpha


  • Gene

    Rho GTPase activating protein 11B


  • Gene

    speedy/RINGO cell cycle regulator family member E12


  • Gene

    DIRAS family GTPase 1



  • Gene

    gamma-glutamyltransferase 5


  • Gene

    coiled-coil domain containing 144A


  • Gene

    peroxisomal biogenesis factor 13


  • Gene

    ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase


  • Gene

    chloride voltage-gated channel Ka

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.